CagriSema vs Tirzepatide vs Retatrutide Compared

CagriSema, tirzepatide and retatrutide are three of the most talked-about metabolic peptides in current research. They are often mentioned in the same breath, but they are built differently and engage different receptor systems. This comparison breaks down what separates them so you can decide which fits your research direction, and how to source them cleanly in Canada.

The quick version

CagriSema: a combination, not a single agonist

CagriSema is different from the other two in an important structural way. It is not one molecule that hits several receptors; it is a fixed combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a GLP-1 receptor agonist. Because amylin sits outside the incretin family, CagriSema brings a signalling axis that neither tirzepatide nor retatrutide touches. That makes it a genuinely distinct point of comparison rather than just a stronger version of the same idea.

Tirzepatide: the dual agonist

Tirzepatide is a single engineered peptide that activates two incretin receptors at once: GIP and GLP-1. Because it is one molecule doing two jobs, it is often used as the reference point when researchers describe what a unimolecular multi-agonist looks like. It is the most established of the three and has the deepest body of published characterisation behind it.

Retatrutide: the triple agonist

Retatrutide extends the multi-agonist idea one step further, adding glucagon receptor activity to GIP and GLP-1. The glucagon component is what makes it distinct: it engages energy expenditure pathways that the dual agonists do not. As a single molecule targeting three receptors, retatrutide is often framed as the most ambitious of the current metabolic peptides in terms of receptor breadth.

How to choose for your research

• Studying amylin signalling alongside GLP-1? CagriSema is the natural choice, because it is the only one of the three that includes an amylin analogue.
• Want the most extensively characterised multi-agonist? Tirzepatide has the longest research track record.
• Interested in glucagon receptor involvement? Retatrutide is the only triple agonist here.

None of the three is simply better than the others. They ask different questions, and the right pick depends on which pathways your protocol is designed around.

The bigger trend behind all three

It helps to see these compounds as points on a single trajectory. Metabolic peptide research began with single-target agonists, then moved toward molecules and combinations that engage more of the metabolic network at once. Tirzepatide represents the dual-agonist step, retatrutide pushes to three receptors in one molecule, and CagriSema takes a different route by combining two peptides to add an amylin axis. Reading them side by side shows you not just three products but the direction the whole field is heading, which is useful context whenever a newer compound appears and you need to place it quickly.

It is also worth remembering that receptor breadth is not the only variable. Half-life, how the molecule is engineered, and how each receptor arm is balanced all shape what a compound is useful for. Two peptides can share a receptor target and still behave differently in a protocol, so the comparison table is a starting point, not the final word.

Sourcing these peptides in Canada

Whichever you choose, identity and purity are what make results reproducible. Every peptide we carry at LYFE Science is verified by HPLC and mass spectrometry, with a certificate of analysis available per lot. We are a Canadian supplier and ship Canada-wide by Canada Post, flat $25 and free over $150, in neutral packaging. Pay by Interac e-Transfer or crypto (BTC, ETH, SOL, USDC, USDT); orders paid before noon Eastern ship the same day, and most of Canada receives delivery in one to three business days.

Bottom line

CagriSema is a two-peptide combination adding an amylin axis, tirzepatide is a dual GIP and GLP-1 agonist, and retatrutide is a triple GIP, GLP-1 and glucagon agonist. Match the receptor coverage to your research question, then source from a supplier that documents every lot.

Shop metabolic research peptides in Canada